Lv4
470 积分 2024-10-24 加入
Global and regional burden of 34 key pathogens in the elderly population in 2021: A systematic analysis of the global burden of disease study 2021
2个月前
已完结
Global antibiotic resistance surveillance report 2025
2个月前
已完结
Global antibiotic resistance surveillance report 2025
2个月前
已关闭
Global antibiotic resistance surveillance report 2025
2个月前
已完结
An Update on Existing and Emerging Data for Meropenem-Vaborbactam
6个月前
已完结
Geographic patterns of global isolates of carbapenem-resistant Klebsiella pneumoniae and the activity of ceftazidime/avibactam, meropenem/vaborbactam, and comparators against these isolates: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2020
7个月前
已完结
In vitro activity and genomic characterization of KPC-producing Klebsiella pneumoniae clinical blood culture isolates resistant to ceftazidime/avibactam, meropenem/vaborbactam, imipenem/relebactam: an Italian nationwide multicentre observational study (2022–23)
7个月前
已完结
Poor in vitro activity of ceftazidime/avibactam, ceftolozane/tazobactam, and meropenem/vaborbactam against carbapenem-resistant Pseudomonas aeruginosa in India: Results from the Antimicrobial Testing Leadership and Surveillance (ATLAS) program, 2018–2021
7个月前
已完结
In vitro activity of imipenem/relebactam, meropenem/vaborbactam and comparators against Pseudomonas aeruginosa in Taiwan: Results from the Study for Monitoring Antimicrobial Resistance Trends (SMART) in 2020
7个月前
已完结
皖公网安备34019202002308
